PW Medtech GroupFRA:PWE -0.93%84 Pretax Margin % is 15.12% as of Dec. 2025, which is 53% below its 10-year median of 32.06. GuruFocus rates FRA:PWE with a GF Score™ of 84/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, PW Medtech Group ranks better than 85.07% on this metric.
The historical rank and industry rank for PW Medtech Group's Pretax Margin % or its related term are showing as below:
FRA:PWE'
s Pretax Margin % Range Over the Past 10 Years
Min: 15.71 Med: 32.06 Max: 271.73
Current: 20.01
FRA:PWE's Pretax Margin % is ranked better than 85.07% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs FRA:PWE: 20.01
PW Medtech Group (FRA:PWE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
PW Medtech Group Pretax Margin % Related Terms
PW Medtech Group Pretax Margin % Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (FRA:PWE) has a Pretax Margin % of 15.12% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PW Medtech Group and its competitors. This is 53% below median its historical median of 32.06. Over the past decade, PW Medtech Group's Pretax Margin % has ranged from 15.71 to 271.73. According to the industry distribution chart, PW Medtech Group ranks #122 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 14.9%.
Is PW Medtech Group's Pretax Margin % too high?
PW Medtech Group's current Pretax Margin % of 15.12% is 53% below median its 10-year median of 32.06. Over the past 10 years, this metric has ranged from a low of 15.71 to a high of 271.73. The Medical Devices & Instruments industry median Pretax Margin % is 2.40. PW Medtech Group's value of 15.12% is 530% above this industry median. Based on the distribution chart, PW Medtech Group ranks #122 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #122 out of 817 companies for Pretax Margin %. This places PW Medtech Group in the top 15% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.40. PW Medtech Group's value of 15.12% is 530% above this benchmark. Historically, PW Medtech Group's own Pretax Margin % has ranged from 15.71 to 271.73 over the past decade. While the company's 10-year median is 32.06 vs. the industry median of 2.40, PW Medtech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current Pretax Margin % of 15.12% is 530% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Pretax Margin % is 15.12%, which is 53% below median its own 10-year median of 32.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Pretax Margin % of 15.12%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 17.7% below its estimated fair value. The current Pretax Margin % is 15.12%, which is 53% below median its 10-year median of 32.06 and 530% above the Medical Devices & Instruments industry median of 2.40. PW Medtech Group's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Pretax Margin % is 15.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 17.7% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
Pretax Margin %: 15.12% (53% below median its 10-year median of 32.06)
GF Value™: €0.13 vs. price of €0.11 (17.7% below fair value)
Industry Position: 530% above the Medical Devices & Instruments median (#122 of 817)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
84GF Score
Get the complete analysis for FRA:PWE
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
